 |
|
Severe Childhood Pneumonia Linked To Specific Strain Of Staphylococcus Aureus (p 753)
February 28, 2002Authors of a French study in this week's issue of THE LANCET highlight the link between a specific strain of the bacterium Staphylococcus aureus and a severe form of pneumonia in children.
Between 1986 and 1998, eight cases of community-acquired pneumonia due to S aureus strains carrying the gene for the Panton-Valentine leukocidin (PVL) were recorded in France, six of which were fatal. Jerome Etienne from the Centre Hospitalo-Universitaire of Lyon, France, aimed to assess the clinical features of these eight cases, and those of other cases identified prospectively, and to compare them with the characteristics of patients with pneumonia caused by PVL-negative strains.
Eight retrospective and eight prospective cases of PVL-positive S aureus pneumonia were compared with 36 cases of PVL-negative S aureus pneumonia. The investigators recorded age, length of hospital stay, risk factors for infection, signs and symptoms, laboratory findings, antibiotic treatment, and serial radiological findings for all patients.
The average age was around 15 years for patients with PVL-positive S aureus compared with 70 years for patients who had PVL-negative strains. Influenza-like illness had occurred during the 2 days before hospital admission in 12 of the 16 PVL-positive patients, but in only three of 33 PVL-negative patients. Markers for PVL-positive infections included temperature (greater than 39°C), heart rate above 140 beats per minute, and a reduction in white-blood cells (leucopenia). The survival rate two days after admission was 63% for the PVL-positive patients and 94% for PVL-negative individuals.
Jerome Etienne comments: "PVL-positive strains of S aureus can complicate influenza-like illness in otherwise healthy children and young adults, with rapid progression to severe pneumonia. Although the comparison of the disease manifestations after infection with PVL-positive or PVL-negative S aureus is complicated by the difference in age of the typical patients, we note that the younger and previously healthier group are more at risk of death than their elderly and infirm counterparts."
Lancet
Pneumonia News and Current Pneumonia Events RSSSilver is the key to reducing pneumonia associated with breathing tubes
People have long prized silver as a precious metal. Now, silver-coated endotracheal tubes are giving critically ill patients another reason to value the lustrous metal.
Bacterial pneumonia caused most deaths in 1918 influenza pandemic
The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Infection Blocks Lung's Protective Response Against Tobacco Smoke
An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health.
Aspirin, acid blocker a-day keeps GI bleeding
For patients with clogged heart arteries who take long-term, low-dose aspirin to prevent a cardiac event, adding a stomach acid-blocking drug to their daily routine has been shown to reduce their risk for upper gastrointestinal bleeding - an infrequent, but serious side-effect of regular aspirin use.
Vaccinated infants well protected against severe pneumococcal infection in Norway
Pneumococcus is a bacterium that can cause serious illnesses in some young children, e.g. meningitis, blood poisoning and pneumonia. Most of those who become ill are previously healthy without any known predisposing factors. The bacterium is present in the nose of up to 80 - 90% of healthy young children.
From foe to friend: Researchers use salmonella as a way to administer vaccines in the body
Researchers at the Biodesign Institute at Arizona State University have made a major step forward in their work to develop a biologically engineered organism that can effectively deliver an antigen in the body. The researchers report that they have been able to use live salmonella bacterium as the containment/delivery method for an antigen.
Yale researchers discover Legionnaire microbe's tricks
Yale University researchers have shed new light how bacteria like the ones that cause Legionnaires' disease and Q-fever raise such havoc in human patients.
Clinical study shows biological and clinical activity in relapsed leukemia patients
Finbarr Cotter, M.D., Ph.D., Professor of the Institute of Cell and Molecular Science at Barts and The London School of Medicine, today presented in an oral session "Clinical Caspase Activation in CLL by GCS-100: a Phase 2 Study" at the 10th International Conference on Malignant Lymphoma (10-ICML).
Despite vaccine, public should not get complacent about pneumococcal disease
Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston.
Gene therapy increases survival for end-stage head and neck cancer
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.
More Pneumonia News Articles
 | Nosocomial Pneumonia: Strategies for Management This multi-contributed text, co-ordinated by one of the leading authorities in the field, is a unique resource to cover in depth the management of the important issue of Nosocomial Pneumonia in respiratory medicine and critical care. This disease presents the clinician with a variety of challenges, in both diagnosis and management, all of which represent a significant concern for the welfare of... |
 | Sepsis: New Strategies for Management Sepsis is an important public health problem around the world. Severe sepsis carries significant morbidity, mortality and high costs. The incidence of sepsis is increasing because of the aging population, the growing number of immunocompromised hosts, the increasing use of invasive procedures, and, to a lesser extent, antibiotic resistance among pathogens. Despite recent advances in the... |
 | Pneumonia Before Antibiotics: Therapeutic Evolution and Evaluation in Twentieth-Century America by Scott H. Podolsky Pneumonia -- Osler's "Captain of the Men of Death" and still the leading infectious cause of death in the United States -- has until now received scant attention from historians. In Pneumonia Before Antibiotics, clinician-historian Scott H. Podolsky uses pneumonia's enduring prevalence and its centrality to the medical profession's therapeutic self-identity to examine the evolution of... |
 | Community-Acquired Pneumonia Pneumonia (along with influenza) is the sixth leading cause of death in adults. About 4 million adults develop pneumonia each year in the US, resulting in 64 million days of restricted activity, 39 million days of bed confinement, and 10 million days of lost work. Yet the admission rates to hospital, length of stay, investigations, antimicrobial therapy and prevention strategies vary greatly... |
| Pneumonia Essentials 2008 by Burke A. Cunha Pneumonia Essentials is a concise, practical, and authoritative guide to the diagnosis, evaluation, treatment, and prevention of community-acquired pneumonia (CAP), nursing home-acquired pneumonia (NHAP), nosocomial (hospital-acquired) pneumonia (NP), tuberculosis (TB), chronic pneumonias, and pneumonias in the immunocompromised... | |
 | The Flu And Pneumonia Update (Disease Update) by Alvin Silverstein, Virginia B. Silverstein, Laura Silverstein Nunn |
| Pneumonia by R. Heffron, Introduction by Maxwell Finland. The Biology of Pneumococcus by B. White, New Foreword by Robert Austin (Commonwealth Fund Publications) by Roderick Heffron, Benjamin White | |
 | Contemporary Diagnosis and Management of Community-Acquired Pneumonia by G. Douglas, M.D. Campbell Community-acquired pneumonia is a growing problem, particularly among the elderly in hospitals and nursing homes. This practical reference outlines the latest antibiotic regimens to combat this life-threatening... |
| Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 150 disorders characterized by scarring or fibrosis of the lungs. In Pulmonary Arterial Hypertension and Interstitial Lung Disease: A Clinical Guid, renowned experts provide a state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. Divided into two sections, the... | |
 | SARS: La Nueva Plaga (SARS: The New Plague) by Ma. del Socorro Alcala Iberri |
| © 2008 BrightSurf.com |